Safranal's Neurological Nexus: Unveiling Therapeutic Potential through Molecular Docking

Muhammad Wasim,Ahmad, Saara

DOI: https://doi.org/10.1134/s1819712424700077

2024-10-28

Neurochemical Journal

Abstract:Safranal, a bioactive compound derived from saffron, has emerged as a subject of growing interest in the quest for novel therapeutics targeting neurological disorders. This research article explores safranal's neurological nexus by employing molecular docking techniques to elucidate its potential as a therapeutic agent. As several neurological disorders constitute a significant global health challenge, necessitating innovative approaches for effective treatment. Safranal, with its recognized neuroprotective, antioxidant, and anti-inflammatory properties, offers a promising avenue for intervention. To unravel its mechanisms of action, molecular docking studies have become invaluable tools. In this comprehensive investigation, an in-depth analysis of safranal's neuropharmacological properties and its interactions with critical molecular targets implicated in neurological disorders has been investigated. Through molecular docking simulations, specific binding affinities and modes of safranal with key receptors, enzymes, and signaling pathways in the central nervous system have been explored. Our study delves into safranal's potential applications in addressing neurodegenerative diseases, including Alzheimer's, Parkinson's, epilepsy, autism as well as its impact on mood disorders such as depression and anxiety. The findings presented herein underscore safranal's remarkable therapeutic potential within the realm of neurology, shedding light on its molecular interactions with pivotal targets. Safranal's neuroprotective attributes, as unveiled through molecular docking, offer novel prospects for addressing a spectrum of neurological disorders, warranting further exploration through animal modeling, preclinical and clinical investigations.

neurosciences